Jessica Nye, PhD

Researchers evaluated protection conferred by 2- and 3-doses of the COVID-19 BNT162b2 vaccine among adolescents during the Delta and Omicron periods.

Researchers evaluated the prevalence of transmitted drug resistance among patients newly diagnosed with HIV infection.

Researchers evaluated the performance of cardiovascular risk prediction models among patients with HIV infection.

Researchers evaluated the safety and immune responses of 3 vaccine regimens for protection against Ebola virus disease among adults and children.

Researchers investigated whether adverse effects in patients with MSSA receiving ceftriaxone are dose-dependent.

Researchers analyzed interactions in the respiratory tract between SARS-CoV-2, influenza A virus, and respiratory syncytial virus.

Researchers surveyed clinicians across Africa to evaluate access to diagnostic testing for HIV-associated fungal infections.

Researchers sought to report the frequency of 4 genetic variants in additional PML cases.

Researchers evaluated whether HIV DNA persists in the liver among individuals receiving suppressive antiretroviral therapy.

Researchers conducted a systematic review to assess the safety and efficacy of various antivirals for the treatment of monkeypox virus infection.

Researchers evaluated clinical and metabolic changes among patients with HIV who switched to first-line treatment with TDF/3TC+DTG.

Researchers evaluated the demographic, clinical, and laboratory characteristics of patients hospitalized with COVID-19 infection.

Researchers evaluated the effects of remdesivir on mortality risk among patients hospitalized with COVID-19 outside of the clinical trial setting.

Researchers investigated the burden of liver disease and causes of significant liver damage among patients with HIV infection.

Researchers examined the association between pneumococcal carriage and COVID-19 infection.

Researchers assessed protection against COVID-19 Delta and Omicron infection among adolescents who were either vaccinated, previously infected, or had hybrid immunity.

Researched evaluated the use of tixagevimab-cilgavimab as post-exposure prophylaxis against symptomatic COVID-19 infection.

Researchers evaluated alternative strategies to boost immune responses to COVID-19 vaccination among kidney transplant recipients.

Researchers surveyed US clinicians to evaluate use of the Meningitis/Encephalitis FilmArray panel in clinical practice.

Researchers evaluated rates of infection-related and infection-unrelated cancers among younger and older adults with HIV infection.

Researchers sought to assess whether individuals with hypertension have a higher risk for severe COVID-19 compared with those without hypertension and whether systolic blood pressure or the type of antihypertensive medication affects that risk.

Researchers evaluated the association between obesity-related single nucleotide polymorphisms and weight gain after antiretroviral therapy initiation.

Researchers evaluated risk factors associated with persistent COVID-19 symptoms 1 year after the acute phase of infection.

Researchers evaluated the prevalence and risk factors for bacterial enteric pathogen detection among men who have sex with men.

Researchers evaluated the efficacy of 12- and 24-week bepirovirsen treatment in participants with chronic hepatitis B virus infection.

Researchers evaluated risk factors of hepatitis B virus (HBV) replication among patients with HBV and HIV coinfection receiving tenofovir-based antiretroviral therapy.

Researchers assessed the risk for secondary monkeypox transmission among individuals who were exposed to the first US patient diagnosed with the infection.

Researchers evaluated the effect of influenza vaccination on reducing antibiotic prescription outcomes for adults diagnosed with influenza-like illness.

Researchers assessed virologic outcomes and risk factors for virologic failure among younger adults with perinatally- and nonperinatally-acquired HIV infection.

Researchers evaluated whether finerenone treatment protects against pneumonia and COVID-19 in patients with chronic kidney disease and type 2 diabetes.